VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 295 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2018. The put-call ratio across all filers is 2.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $8,927,000 | +29.8% | 384,141 | -11.1% | 0.05% | +6.4% |
| Q1 2018 | $6,879,000 | -20.3% | 432,093 | +4.1% | 0.05% | -17.5% |
| Q4 2017 | $8,628,000 | +50.2% | 415,202 | +3.5% | 0.06% | +39.0% |
| Q3 2017 | $5,746,000 | -17.2% | 401,002 | 0.0% | 0.04% | -22.6% |
| Q2 2017 | $6,938,000 | +2074.9% | 401,002 | +1285.5% | 0.05% | +2550.0% |
| Q1 2017 | $319,000 | -48.2% | 28,942 | +737.4% | 0.00% | -75.0% |
| Q3 2015 | $616,000 | -59.6% | 3,456 | -49.6% | 0.01% | -52.9% |
| Q2 2015 | $1,524,000 | +89.3% | 6,859 | +69.3% | 0.02% | +88.9% |
| Q1 2015 | $805,000 | +44.8% | 4,052 | +4.4% | 0.01% | +28.6% |
| Q4 2014 | $556,000 | -3.3% | 3,883 | -11.4% | 0.01% | 0.0% |
| Q3 2014 | $575,000 | +27.5% | 4,381 | +22.6% | 0.01% | -12.5% |
| Q2 2014 | $451,000 | +0.7% | 3,573 | +5.1% | 0.01% | 0.0% |
| Q1 2014 | $448,000 | +62.9% | 3,400 | +45.2% | 0.01% | +33.3% |
| Q4 2013 | $275,000 | 0.0% | 2,341 | -11.3% | 0.01% | 0.0% |
| Q3 2013 | $275,000 | +21.1% | 2,639 | 0.0% | 0.01% | 0.0% |
| Q2 2013 | $227,000 | – | 2,639 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |